Get started
Author

Juan José Carreras

Observed names: Carreras Martínez, Juan José, Carreras-Martínez, Juan José, Juan J Carreras, Juan J. Carreras, Juan Jose Carreras, Juan José Carreras-Martínez, Juan-José Carreras
Observed institutions: Universitat de València, Instituto de Salud Carlos III, Generalitat Valenciana, Conselleria de Sanitat Universal i Salut Pública, Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana, Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública
ORCID: 0000-0002-5725-8972
Observed ORCID: 0000-0002-5725-8972
OpenAlex ID: A5044509456
Ultraflexible lipid vesicles allow topical absorption of cyclosporin A
2019 · Juan J Carreras, Willian E Tapia-Ramirez, et al. · Drug Delivery and Translational Research · 51
Targeted delivery of Cyclosporine A by polymeric nanocarriers improves the therapy of inflammatory bowel disease in a relevant mouse model
2017 · Ana Melero, Christina Draheim, et al. · European Journal of Pharmaceutics and Biopharmaceutics · 45
Lipid Nanoparticles as Potential Gene Therapeutic Delivery Systems for Oral Administration
2017 · Golnar Dorraj, Juan Jose Carreras, et al. · Current Gene Therapy · 18
Risk of Guillain-Barré syndrome after COVID-19 vaccination or SARS-CoV-2 infection: A multinational self-controlled case series study
2025 · Sharifa Nasreen, Yannan Jiang, et al. · Vaccine · 12
Trends of Adverse Events Following Immunization (AEFI) Reports of Human Papillomavirus Vaccine in the Valencian Community—Spain (2008–2018)
2020 · Cecilia M. Egoavil, José Tuells, et al. · Vaccines · 10
PDF
Post-Marketing Surveillance of Nirsevimab: Safety Profile and Adverse Event Analysis from Spain’s 2023–2024 RSV Immunisation Campaign
2025 · Pablo Estrella-Porter, Elisa Correcher-Martínez, et al. · Vaccines · 8
PDF
Effect of freezing and storage temperature on stability and antimicrobial activity of an antibiotic mixture used for decontamination of tissue allografts
2018 · Vicente Mirabet, Ana Melero, et al. · Cell and Tissue Banking · 7
A comparison of four self-controlled study designs in an analysis of COVID-19 vaccines and myocarditis using five European databases
2024 · Anna Schultze, Ivonne Martin, et al. · Vaccine · 6
Applying two approaches to detect unmeasured confounding due to time-varying variables in a self-controlled risk interval design evaluating COVID-19 vaccine safety signals, using myocarditis as a case example
2024 · Sophie H Bots, Svetlana Belitser, et al. · American Journal of Epidemiology · 5
Incidence of severe and non-severe SARS-CoV-2 infections in children and adolescents: a population-based cohort study using six healthcare databases from Italy, Spain, and Norway
2024 · Carlos E. Durán, Fabio Riefolo, et al. · European Journal of Pediatrics · 3
Acontecimientos adversos en embarazadas con la vacuna tetravalente contra la gripe obtenida de cultivos celulares
2022 · Juan José Carreras, José Antonio Lluch, et al. · Enfermedades Infecciosas y Microbiología Clínica · 3
Incidence of Guillain–Barré Syndrome Following COVID-19 Vaccination and SARS-CoV-2 Infection: A Population-Based Cohort Study Using the Valencia Health System Integrated Database (Spain)
2026 · Elisa Correcher-Martínez, Sergio Pascual Viciedo-Mata, et al. · Pharmaceuticals · 1
PDF
Evaluation of the MenACWY Vaccination Catch-Up Campaign Among Adolescents in Madrid: Coverage, Trends, and Determinants
2026 · Pablo Estrella-Porter, Amaya Sánchez-Gómez, et al. · Vaccines · 1
PDF
Adverse events in pregnant women with the tetravalent influenza vaccine obtained from cell cultures
2022 · Juan José Carreras, José Antonio Lluch, et al. · Enfermedades infecciosas y microbiologia clinica (English ed ) · 1
Validation of Guillain-Barré syndrome case identification in three heterogeneous VAC4EU real-world data sources in Spain using the Brighton Collaboration criteria
2026 · Mònica Sabaté, Judit Riera-Arnau, et al. · Vaccine
Harmonizing Case Validation for Vaccine Safety in Real-World Data: The VAC4EU Experience
2026 · Amirreza Dehghan Tarazjani, Daniel Weibel, et al. · Clinical Epidemiology
PDF
Developing a Comprehensive Framework for Real-World Data Case Validation in Vaccine Safety Monitoring: The VAC4EU experience
2025 · Amirreza Dehghan Tarazjani, Daniel Weibel, et al. · medRxiv
PDF
Clinical Course, Outcomes, and Risk Factors of Myocarditis and Pericarditis Following Administration of mRNA-1273 Vaccination: A Protocol for a Federated Real-World Evidence Vaccine Safety Study Using Data from Five European Data Sources
2025 · Laura C. Zwiers, Diederick E. Grobbee, et al. · Vaccines
PDF
Corrigendum to “A comparison of four self-controlled study designs in an analysis of COVID-19 vaccines and myocarditis using five European databases” [Vaccine 42 (12) (2024) 3039–3048]
2024 · Anna Schultze, Ivonne Martin, et al. · Vaccine
Works count: 23
Citation count: 173
H-index: 7
I10-index: 5
Year
Topic
Type